This educational Whiteboard Snapshot program offers ophthalmologists and retina specialists an opportunity to recognize key patient factors that contribute to suboptimal initiation and adherence to anti-VEGF therapy in the management of nAMD, DME, and RVO. Through engaging whiteboard animations, participants will discover practical, evidence-based strategies to identify and overcome patient barriers, helping ensure equitable and optimal vision outcomes for patients living with retinal disease.

RELEASED DATE: December 10, 2025
EXPIRATION DATE: February 10, 2027

This program addresses disparities in patient care concerning the treatment of neovascular age-related macular degeneration (nAMD), diabetic macular edema (DME), and retinal vein occlusion (RVO). Participants will learn to identify key patient factors driving inadequate initiation of and adherence to anti-VEGF therapy. Through case studies, they will examine how racial, ethnic, and socioeconomic disparities elevate risks of vision loss, increase loss to follow up, and worsen visual outcomes. The program also underscores the critical need for a more diverse ophthalmology workforce to improve access to care.

RELEASED DATE: November 14, 2025
EXPIRATION DATE: November 14, 2026

This educational Whiteboard Educational Snapshot activity offers clinicians involved in the care of pediatric patients the opportunity to learn about recent evidence in the management of retinopathy of prematurity (ROP), including efficacy and safety of anti-VEGF therapy. Through interactive whiteboard animations and case-based learning, clinicians can increase their ability to individualize management plans in ROP.

RELEASED DATE: May 06, 2026
EXPIRATION DATE: May 06, 2027

Tuesday, August 18, 2026

12:00 p.m. – 1:00 p.m. ET

Please note this TeleECHO program is 12:00 p.m. Eastern, 11:00 a.m. Central, 10:00 a.m. Mountain and 9:00 a.m. Pacific.

Wednesday, August 12, 2026

3:00 p.m. – 4:00 p.m. ET

Please note this TeleECHO program is 3:00 p.m. Eastern, 2:00 p.m. Central, 1:00 p.m. Mountain and 12:00 p.m. Pacific.

Wednesday, August 5, 2026

2:00 p.m. – 3:00 p.m. ET

Please note this TeleECHO program is 2:00 p.m. Eastern, 1:00 p.m. Central, 12:00 p.m. Mountain and 11:00 a.m. Pacific.

Thursday, July 30, 2026

8:00 p.m. – 9:00 p.m. ET

Please note this TeleECHO program is 8:00 p.m. Eastern, 7:00 p.m. Central, 6:00 p.m. Mountain and 5:00 p.m. Pacific.

This enduring activity targets healthcare gaps related to awareness of health disparities in the prevention and treatment of ocular diseases and the importance of diverse representation within clinical trials and the ophthalmology workforce, impacting outcomes through assessing for factors that can contribute to disparities in vision health and strategies to overcome them.

This online program targets critical issues in diabetic retinopathy, including the importance of screening and early detection of retinopathy, how early treatment in retinopathy can help prevent progression to vision-threatening complications, and the advantageous impact of multidisciplinary management in the care of a retinopathy patient. Learn essential elements of screening, referral, and treatment, as well as core systemic factors affecting risk for both development and worsening of diabetic eye disease, which when optimized can help preserve vision in diabetes.

This educational Whiteboard MicroModule program offers healthcare professionals involved in the care of patients with retinal diseases an opportunity to learn about recent evidence on anti-VEGF agents in the management of nAMD and DME. Through interactive whiteboard animations, participants will examine results of recent long-term extensions of pivotal clinical trials and real-world studies on next-generation anti-VEGFs to support their role in optimizing patient outcomes.

RELEASED DATE: March 25, 2026
EXPIRATION DATE: May 22, 2027